BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

779 related articles for article (PubMed ID: 17295170)

  • 1. [Polish forum for prevention guidelines on cardiovascular risk assessment].
    Podolec P; Kopeć G; Pajak A; Undas A; Kozek E; Tykarski A; Naruszewicz M; Stańczyk J; Opala G; Godycki-Cwirko M; Rynkiewicz A; Torbicki A; Musiał J
    Kardiol Pol; 2007 Jan; 65(1):100-4. PubMed ID: 17295170
    [No Abstract]   [Full Text] [Related]  

  • 2. The things to come of SHAPE: cost and effectiveness of cardiovascular prevention.
    Diamond GA; Kaul S
    Am J Cardiol; 2007 Apr; 99(7):1013-5. PubMed ID: 17398203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum.
    Smith SC; Jackson R; Pearson TA; Fuster V; Yusuf S; Faergeman O; Wood DA; Alderman M; Horgan J; Home P; Hunn M; Grundy SM
    Circulation; 2004 Jun; 109(25):3112-21. PubMed ID: 15226228
    [No Abstract]   [Full Text] [Related]  

  • 4. [Position paper on the primary prevention of cardiovascular diseases. Current position of the 25.3.2003 Statement of the Board of the German Society of Cardiology--heart and circulatory research work commissioned by for the board by Project Group on Prevention].
    Gohlke H; Kübler W; Mathes P; Meinertz T; Schuler G; Gysan DB; Sauer G;
    Z Kardiol; 2005; 94 Suppl 3():III/113-5. PubMed ID: 16258788
    [No Abstract]   [Full Text] [Related]  

  • 5. The prevention of cardiovascular disease: have we really made progress?
    Pearson TA
    Health Aff (Millwood); 2007; 26(1):49-60. PubMed ID: 17211013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time for results: a better way to reduce cardiovascular risk.
    Mola A; Lloyd M
    Adv Nurse Pract; 2002 Apr; 10(4):34-41; quiz 42-3. PubMed ID: 12418348
    [No Abstract]   [Full Text] [Related]  

  • 7. Risk assessment for prevention of morbidity and mortality: lessons for pressure ulcer prevention.
    Reynolds TM
    J Tissue Viability; 2008 Nov; 17(4):115-20. PubMed ID: 19061825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [European Guidelines on Cardiovascular Disease Prevention in the Clinical Practice. Third work group of the european societies and other societies on cardiovascular disease prevention in the clinical practice].
    de Backer G; Ambrosioni E; Borch-Johnsen K; Brotons C; Cifkova R; Dallongeville J; Ebrahim S; Faergeman O; Graham I; Mancia G; Manger Cats V; Orth-Gomer K; Perk J; Pyorala K; Rodicio JL; Sans S; Sansoy V; Sechtem U; Silber S; Thomsen T; Wood D
    Neurologia; 2004 Oct; 19(8):440-50. PubMed ID: 15470585
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevention and screening. Part II: Critical appraisal of articles on screening.
    Soares I; Carneiro AV
    Rev Port Cardiol; 2003 Jan; 22(1):117-30. PubMed ID: 12712815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On reducing cardiovascular disease to a rarity: clinical strategies and their cost-effectiveness.
    Lewis B; Watts GF; Sullivan DR
    Heart Lung Circ; 2010 Apr; 19(4):225-7. PubMed ID: 20149730
    [No Abstract]   [Full Text] [Related]  

  • 11. Translating guidelines to practice: findings from a multidisciplinary preventive cardiology programme in the west of Ireland.
    Gibson I; Flaherty G; Cormican S; Jones J; Kerins C; Walsh AM; Costello C; Windle J; Connolly S; Crowley J
    Eur J Prev Cardiol; 2014 Mar; 21(3):366-76. PubMed ID: 23884981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost and effectiveness of cardiovascular prevention.
    Boyar A
    Am J Cardiol; 2007 Nov; 100(9):1492-4; author reply 1494-5. PubMed ID: 17950815
    [No Abstract]   [Full Text] [Related]  

  • 13. [The Medical Products Agency's new guidelines for primary prevention of cardiovascular diseases. No help to physicians].
    Berglund G
    Lakartidningen; 2006 Nov 22-28; 103(47):3694-5. PubMed ID: 17212315
    [No Abstract]   [Full Text] [Related]  

  • 14. Polish Forum for Prevention Guidelines on the so-called new cardiovascular risk factors and markers, which have a potentially significant role in the strategy for the prevention of cardiovascular diseases.
    Undas A; Podolec P; Kopeć G; Pajak A; Gasior Z; Małecki M; Pasowicz M; Rynkiewicz A; Torbicki A; Zdrojeski T; Czarnecka D; Drygas W; Godycki-Cwirko M; Kozek E; Naruszewicz M; Opala G; Stańczyk J; Sieradzki J
    Kardiol Pol; 2007 Nov; 65(11):1396-8. PubMed ID: 18303602
    [No Abstract]   [Full Text] [Related]  

  • 15. Progress in prevention: should we screen for risk factors or disease? A current debate in the prevention of cardiovascular events.
    Dennison CR; Hughes S
    J Cardiovasc Nurs; 2009; 24(1):18-20. PubMed ID: 19114796
    [No Abstract]   [Full Text] [Related]  

  • 16. [Primary prevention of cardiovascular disease should be based on absolute risk assessment].
    Nilsson PM
    Lakartidningen; 2005 Feb 14-20; 102(7):496-7. PubMed ID: 15768700
    [No Abstract]   [Full Text] [Related]  

  • 17. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).
    Graham I; Atar D; Borch-Johnsen K; Boysen G; Burell G; Cifkova R; Dallongeville J; De Backer G; Ebrahim S; Gjelsvik B; Herrmann-Lingen C; Hoes A; Humphries S; Knapton M; Perk J; Priori SG; Pyorala K; Reiner Z; Ruilope L; Sans-Menendez S; Op Reimer WS; Weissberg P; Wood D; Yarnell J; Zamorano JL; Walma E; Fitzgerald T; Cooney MT; Dudina A; Vahanian A; Camm J; De Caterina R; Dean V; Dickstein K; Funck-Brentano C; Filippatos G; Hellemans I; Kristensen SD; McGregor K; Sechtem U; Silber S; Tendera M; Widimsky P; Zamorano JL; Altiner A; Bonora E; Durrington PN; Fagard R; Giampaoli S; Hemingway H; Hakansson J; Kjeldsen SE; Larsen ML; Mancia G; Manolis AJ; Orth-Gomer K; Pedersen T; Rayner M; Ryden L; Sammut M; Schneiderman N; Stalenhoef AF; Tokgözoglu L; Wiklund O; Zampelas A; ; ; ; ; ; ; ; ; ;
    Eur J Cardiovasc Prev Rehabil; 2007 Sep; 14 Suppl 2():E1-40. PubMed ID: 17726406
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary prevention of cardiovascular diseases by lipid-lowering treatment in German general practice: results from GPs ignoring guidelines and risk calculators.
    Oriol-Zerbe C; Abholz HH
    Eur J Gen Pract; 2007; 13(1):27-34. PubMed ID: 17366291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [From curative to preventive medicine: integral prevention as exemplified by cardiology].
    Lüscher TF
    Schweiz Rundsch Med Prax; 1990 Sep; 79(37):1047-9. PubMed ID: 2218231
    [No Abstract]   [Full Text] [Related]  

  • 20. Quality indicators for the prevention and management of cardiovascular disease in primary care in nine European countries.
    Campbell SM; Ludt S; Van Lieshout J; Boffin N; Wensing M; Petek D; Grol R; Roland MO
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):509-15. PubMed ID: 18695594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.